TY - JOUR AU - Grilli, R. AU - Oxman, A. D. AU - Julian, J. A. PY - 1993 DA - 1993// TI - Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough? JO - J Clin Oncol VL - 11 ID - Grilli1993 ER - TY - JOUR PY - 1995 DA - 1995// TI - Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials JO - BMJ VL - 311 UR - https://doi.org/10.1136/bmj.311.7010.899 DO - 10.1136/bmj.311.7010.899 ID - ref2 ER - TY - JOUR AU - Billingham, L. J. AU - Cullen, M. H. PY - 2001 DA - 2001// TI - The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer JO - Ann Oncol VL - 12 UR - https://doi.org/10.1023/A:1013582618920 DO - 10.1023/A:1013582618920 ID - Billingham2001 ER - TY - JOUR AU - Ramanathan, R. K. AU - Belani, C. P. PY - 1997 DA - 1997// TI - Chemotherapy for non-small cell lung cancer: Past, present and future JO - Semin Oncol VL - 24 ID - Ramanathan1997 ER - TY - JOUR AU - Bonomi, P. AU - Kim, K. M. AU - Fairclough, D. AU - Cella, D. AU - Kugler, J. AU - Rowinsky, E. AU - Jiroutek, M. AU - Johnson, D. PY - 2000 DA - 2000// TI - Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group Trial JO - J Clin Oncol VL - 18 ID - Bonomi2000 ER - TY - JOUR AU - Cardenal, F. AU - Lopez-Cabrerizo, M. P. AU - Anton, A. AU - Alberola, V. AU - Massuti, B. AU - Carrato, A. AU - Barneto, I. AU - Lomas, M. AU - Garcia, M. AU - Lianes, P. AU - Montalar, J. AU - Vadell, C. AU - Gonzalez-Larriba, J. L. AU - Nguyen, B. AU - Artal, A. AU - Rosell, R. PY - 1999 DA - 1999// TI - Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer JO - J Clin Oncol VL - 17 ID - Cardenal1999 ER - TY - JOUR AU - Chang, A. Y. AU - Kim, K. AU - Glick, J. AU - Anderson, T. AU - Karp, D. AU - Johnson, D. PY - 1993 DA - 1993// TI - Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: The Eastern Cooperative Oncology Group results JO - J Natl Cancer Inst VL - 85 UR - https://doi.org/10.1093/jnci/85.5.388 DO - 10.1093/jnci/85.5.388 ID - Chang1993 ER - TY - JOUR AU - Murphy, W. K. AU - Fossella, F. V. AU - Winn, R. J. AU - Shin, D. M. AU - Hynes, H. E. AU - Gross, H. M. AU - Davilla, E. AU - Leimert, J. AU - Dhingra, H. AU - Raber, M. N. PY - 1993 DA - 1993// TI - Phase II study of taxol in patients with untreated advanced non-small cell lung cancer JO - J Natl Cancer Inst VL - 85 UR - https://doi.org/10.1093/jnci/85.5.384 DO - 10.1093/jnci/85.5.384 ID - Murphy1993 ER - TY - JOUR AU - Miller, K. D. AU - Sweeney, C. J. AU - Sledge, G. W. PY - 2001 DA - 2001// TI - Redefining the target: chemotherapeutics as antiangiogenics JO - J Clin Oncol VL - 19 ID - Miller2001 ER - TY - JOUR AU - Schiller, J. H. AU - Harrington, D. AU - Belani, C. P. AU - Langer, C. AU - Sandler, A. AU - Krook, J. AU - Zhu, J. AU - Johnson, D. H. PY - 2002 DA - 2002// TI - Comparison of four chemotherapy regimens for advanced non-small cell lung cancer JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa011954 DO - 10.1056/NEJMoa011954 ID - Schiller2002 ER - TY - JOUR AU - Go, R. S. AU - Adjei, A. A. PY - 1999 DA - 1999// TI - Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin JO - J Clin Oncol VL - 17 ID - Go1999 ER - TY - BOOK PY - 1988 DA - 1988// TI - Common Toxicity Criteria PB - MD CY - Bethesda ID - ref12 ER - TY - JOUR AU - Miller, A. B. AU - Hogestraeten, B. AU - Staquet, M. AU - Winkler, A. PY - 1981 DA - 1981// TI - Reporting results of cancer treatment JO - Cancer VL - 47 UR - https://doi.org/3.0.CO;2-6 DO - 3.0.CO;2-6 ID - Miller1981 ER - TY - JOUR AU - Kaplan, E. L. AU - Meier, P. PY - 1958 DA - 1958// TI - Nonparametric estimation from incomplete observations JO - J Am Stat Assoc VL - 53 UR - https://doi.org/10.1080/01621459.1958.10501452 DO - 10.1080/01621459.1958.10501452 ID - Kaplan1958 ER - TY - JOUR AU - Mantel, N. PY - 1966 DA - 1966// TI - Evaluation of survival data and two new rank order statistics arising in its consideration JO - Cancer Chemother Rep VL - 50 ID - Mantel1966 ER - TY - JOUR AU - Kelly, K. AU - Crowley, J. AU - Bunn, P. A. AU - Presant, C. A. AU - Grevstad, P. K. AU - Moinpour, C. M. AU - Ramsey, S. D. AU - Wozniak, A. J. AU - Weiss, G. R. AU - Moore, D. F. AU - Israel, V. K. AU - Livingston, R. B. AU - Gandara, D. R. PY - 2001 DA - 2001// TI - Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group Trial JO - J Clin Oncol VL - 19 ID - Kelly2001 ER - TY - CHAP AU - Alvarez, A. AU - Mickiewicz AU - Brosio, C. AU - Giglio, R. AU - Cinat, G. AU - Suarez, A. ED - Michael, C. PY - 1998 DA - 1998// TI - Weekly taxol (T) in patients who had relapsed or remained stable with T in a 21 day schedule BT - Proceedings of the American Society of Clinical Oncology: 16–19 May 1998; California PB - WB Saunders CY - Perry ID - Alvarez1998 ER - TY - JOUR AU - Akerley, W. PY - 2000 DA - 2000// TI - Paclitaxel in advanced non-small-cell lung cancer: An alternative high-dose weekly schedule JO - Chest VL - 117 UR - https://doi.org/10.1378/chest.117.4_suppl_1.152S DO - 10.1378/chest.117.4_suppl_1.152S ID - Akerley2000 ER - TY - JOUR AU - Akerley, W. AU - Glantz, M. AU - Choy, H. AU - Rege, V. AU - Sambandam, S. AU - Joseph, P. AU - Yee, L. AU - Rodrigues, B. AU - Wingate, P. AU - Leone, L. PY - 1998 DA - 1998// TI - Phase I trial of weekly paclitaxel in advanced lung cancer JO - J Clin Oncol VL - 16 ID - Akerley1998 ER - TY - JOUR AU - Akerley, W. AU - Herndon, J. AU - Egorin, M. J. AU - Lyss, A. P. AU - Kindler, H. L. AU - Savarese, D. M. AU - Sherman, C. A. AU - Rosen, D. M. AU - Hollis, D. AU - Ratain, M. J. AU - Green, M. R. PY - 2003 DA - 2003// TI - Weekly, high dose paclitaxel in advanced lung carcinoma: A phase II study with pharmacokinetics by the Cancer and Leukemia Group B JO - Cancer VL - 97 UR - https://doi.org/10.1002/cncr.11375 DO - 10.1002/cncr.11375 ID - Akerley2003 ER - TY - JOUR AU - Belani, C. P. AU - Barstis, J. AU - Perry, M. C. AU - La Rocca, R. V. AU - Nattam, S. R. AU - Rinaldi, D. AU - Clark, R. AU - Mills, G. M. PY - 2003 DA - 2003// TI - Multicenter, randomized trial for IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.02.563 DO - 10.1200/JCO.2003.02.563 ID - Belani2003 ER - TY - STD TI - Belani CP: Weekly paclitaxel and carboplatin in non-small cell lung cancer. Lung Cancer. 2000, 128-129. Suppl 2 ID - ref22 ER - TY - JOUR AU - Socinski, M. A. AU - Schell, M. J. AU - Peterman, A. AU - Bakri, K. AU - Yates, S. AU - Gitten, R. AU - Unger, P. AU - Lee, J. AU - Lee, J. H. AU - Tynan, M. AU - Moore, M. AU - Kies, M. S. PY - 2002 DA - 2002// TI - Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.20.5.1335 DO - 10.1200/JCO.20.5.1335 ID - Socinski2002 ER - TY - JOUR AU - Smith, I. E. AU - O'Brien, M. E. R. AU - Talbot, D. C. AU - Nicolson, M. C. AU - Mansi, J. L. AU - Hickish, T. F. AU - Norton, A. AU - Ashley, S. PY - 2001 DA - 2001// TI - Duration of chemotherapy in advanced non-small-cell lung cancer: A randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin JO - J Clin Oncol VL - 19 ID - Smith2001 ER - TY - JOUR AU - Belani, C. P. AU - Kearns, C. M. AU - Zuhowski, E. G. AU - Erkmen, K. AU - Hiponia, D. AU - Zacharski, D. AU - Engstrom, C. AU - Ramanathan, R. K. AU - Capozzoli, M. J. AU - Aisner, J. AU - Egorin, M. J. PY - 1999 DA - 1999// TI - Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer JO - J Clin Oncol VL - 17 ID - Belani1999 ER - TY - JOUR AU - Kearns, C. AU - Egorin, M. PY - 1997 DA - 1997// TI - Considerations regarding the less-than expected thrombocytopenia encountered with combination paclitaxel/carboplatin chemotherapy JO - Semin Oncol VL - 24 ID - Kearns1997 ER - TY - JOUR AU - Belani, C. P. PY - 2000 DA - 2000// TI - Paclitaxel and docetaxel combinations in non-small cell lung cancer JO - Chest VL - 117 UR - https://doi.org/10.1378/chest.117.4_suppl_1.144S DO - 10.1378/chest.117.4_suppl_1.144S ID - Belani2000 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/5/10/prepub UR - http://www.biomedcentral.com/1471-2407/5/10/prepub ID - ref28 ER -